Paper · 28530655
A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.
Rogers ZN and 6 others. Nat Methods, 2017. Cited by 113 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Papers, record 28530655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28530655
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms, Experimental | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Adenocarcinoma | |
| Animals | |
| DNA | |
| DNA Barcoding, Taxonomic | |
| Female | |
| Genetic Engineering | |
| Humans | |
| Lentivirus | |
| Lung | |
| Lung Neoplasms | |
| Male | |
| Mice | |
| Models, Genetic | |
| Plasmids | |
| Proto-Oncogene Proteins p21(ras) |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R25 CA180993 | NCI NIH HHS | United States | R25CA180993 | PubMed and NIH | NIH RePORTER |
| R01 CA175336 | NCI NIH HHS | United States | R01CA175336 | PubMed and NIH | NIH RePORTER |
| R01 CA207133 | NCI NIH HHS | United States | R01CA207133 | PubMed and NIH | NIH RePORTER |
| T32 HG000044 | NHGRI NIH HHS | United States | T32HG000044 | PubMed and NIH | NIH RePORTER |
| R35 GM118165 | NIGMS NIH HHS | United States | R35GM118165 | PubMed and NIH | NIH RePORTER |
| R21 CA194910 | NCI NIH HHS | United States | R21CA194910 | PubMed and NIH | NIH RePORTER |
| S10 OD018220 | NIH HHS | United States | S10OD018220 | PubMed and NIH | NIH RePORTER |
| P30 CA124435 | NCI NIH HHS | United States | P30CA124435 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 28,607,511 | Technique: Sizing up tumours with Tuba-seq. | https://conductscience.org/library/papers/28607511 |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,288,016 | The differential effects of mutant p53 alleles on advanced murine lung cancer. | Cancer Res | 2005 | https://conductscience.org/library/papers/16288016 | PubMed |
| 2 | 22,980,975 | Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. | Cell | 2012 | https://conductscience.org/library/papers/22980975 | PubMed |
| 3 | 11,751,630 | Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. | Genes Dev | 2001 | https://conductscience.org/library/papers/11751630 | PubMed |
| 4 | 26,853,560 | Tumor suppressor properties of the splicing regulatory factor RBM10. | RNA Biol | 2016 | https://conductscience.org/library/papers/26853560 | PubMed |
| 5 | 19,270,154 | Tumor suppressors and cell metabolism: a recipe for cancer growth. | Genes Dev | 2009 | https://conductscience.org/library/papers/19270154 | PubMed |
| 6 | 11,694,875 | Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. | Nat Genet | 2001 | https://conductscience.org/library/papers/11694875 | PubMed |
| 7 | 3,191,483 | A Gompertzian model of human breast cancer growth. | Cancer Res | 1988 | https://conductscience.org/library/papers/3191483 | PubMed |
| 8 | 21,385,881 | Hypoxia and senescence: the impact of oxygenation on tumor suppression. | Mol Cancer Res | 2011 | https://conductscience.org/library/papers/21385881 | PubMed |
| 9 | 17,676,052 | A spatially and temporally restricted mouse model of soft tissue sarcoma. | Nat Med | 2007 | https://conductscience.org/library/papers/17676052 | PubMed |
| 10 | 25,765,070 | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. | Science | 2015 | https://conductscience.org/library/papers/25765070 | PubMed |
1 to 10 of 54
See all 54 referencesCited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,875,424 | Antagonistic roles of histone H3 lysine methyltransferases dictate tumor immune surveillance. | Nat Commun | 2026 | https://conductscience.org/library/papers/42875424 | PubMed |
| 42,818,943 | Quantitative dissection of the metastatic cascade at single colony resolution. | Res Sq | 2026 | https://conductscience.org/library/papers/42818943 | PubMed |
| 42,298,891 | Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42298891 | PubMed |
| 42,297,823 | Tumor suppressor genotype influences the extent and mode of immunosurveillance in lung cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42297823 | PubMed |
| 42,225,068 | Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screens. | Cell Rep Methods | 2026 | https://conductscience.org/library/papers/42225068 | PubMed |
| 42,124,569 | Quantitative dissection of the metastatic cascade at single colony resolution. | bioRxiv | 2026 | https://conductscience.org/library/papers/42124569 | PubMed |
| 41,758,887 | Putting BASIL in a BLT: A Bayesian filtering method for estimating the fitness effects of nascent adaptive mutations. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/41758887 | PubMed |
| 41,705,258 | In vivo multiplexed modeling reveals diverse roles of the TBX2 subfamily and Egr1 in Kr as-driven lung adenocarcinoma. | Genes Dis | 2026 | https://conductscience.org/library/papers/41705258 | PubMed |
| 41,648,157 | Scaling perturbations: beyond genome-scale CRISPR screens. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648157 | PubMed |
| 41,188,600 | Aging represses oncogenic KRAS-driven lung tumorigenesis and alters tumor suppression. | Nat Aging | 2025 | https://conductscience.org/library/papers/41188600 | PubMed |
1 to 10 of 100
See all 100 cited byGenes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARID1A | 8,289 | PubTator's text mining | https://conductscience.org/library/genes/8289 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| DNMBP | 23,268 | PubTator's text mining | https://conductscience.org/library/genes/23268 | NCBI Gene |
| KEAP1 | 9,817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| RBM10 | 8,241 | PubTator's text mining | https://conductscience.org/library/genes/8241 | NCBI Gene |
| SETD2 | 29,072 | PubTator's text mining | https://conductscience.org/library/genes/29072 | NCBI Gene |
| SMAD4 | 4,089 | PubTator's text mining | https://conductscience.org/library/genes/4089 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28530655
GET https://conductscience.org/api/papers/v1/28530655/references?page=2